GNPX - Genprex - Stock Price & Catalysts • BiopharmIQ

Enterprise Value

1.885M

Cash

9.956M

Avg Qtr Burn

-6.067M

Short % of Float

3.27%

Insider Ownership

2.31%

Institutional Own.

15.88%

Qtr Updated

06/30/23

Drug Pipeline

Only showing assets and stage. See catalyst data with a free or premium account. Unlock more data with a free account.

Drug & Indication	Stage & Event	Catalyst Date
REQORSA (quaratusugene ozeplasmid) + Keytruda Details Non-small cell lung carcinoma, Cancer, Lung cancer	Phase 1/2 Update	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REQORSA (quaratusugene ozeplasmid) + Tecentriq Details Cancer, Lung cancer, Small cell lung cancer	Phase 1/2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.
REQORSA (quaratusugene ozeplasmid) + Tagrisso Details Non-small cell lung carcinoma, Lung cancer, Cancer	Phase 1/2 Initiation	Some catalyst date You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details. You must sign up to see the catalyst details.Sign up now.